Viking Therapeutics, Inc. VKTX

US Biotechnology

$29.55 ▲ +1.93% (+$0.56)

⬆️ Above Yest. High 🔥 High Short Interest

Open $28.92

Prev Close $28.99

Day Range $28.42 – $30.11

52W Range $23.82 – $43.15

Market Cap $3.48B

Beta 0.79

EPS (TTM) $-4.66

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2015-04-29
Shares Out.	127,520,000
Website	vikingtherapeutics.com/ ↗
Phone	18009279800
Employees	74
Revenue	$0
Gross Profit	$0
Net Income	-$183.2M
Free Cash Flow	-$462.6M
Total Assets	$977.2M
Total Liabilities	$388.6M
Equity	$588.6M

About Viking Therapeutics, Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Viking Therapeutics, Inc. is a publicly traded company under the ticker symbol VKTX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.